The global Buspirone market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Buspirone, sold under the brand name Buspar among others, is a medication primarily used to treat anxiety disorders, particularly generalized anxiety disorder. Benefits support its short term use. It has not been found to be effective in treating psychosis. It is taken by mouth, and it may take up to four weeks for an effect.
This report aims to provide a comprehensive presentation of the global market for Buspirone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Buspirone. This report contains market size and forecasts of Buspirone in global, including the following market information:
Global Buspirone Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global Buspirone Market Sales, 2018-2023, 2024-2035, (K Units)
Global top five Buspirone companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
5mg Segment to Reach $ Million by 2035, with a % CAGR in next six years.
The global key manufacturers of Buspirone include Bristol Myers Squibb, Apotex, Dr. Reddy's Laboratories, Laboratoires Servier, Teva, AMAG Pharmaceuticals, Mylan, Novartis and Watson Laboratories, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Buspirone manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Buspirone Market, by Type, 2018-2023, 2024-2035 ($ Millions) & (K Units)
Global Buspirone Market Segment Percentages, by Type, 2022 (%)
Global Buspirone Market, by Application, 2018-2023, 2024-2035 ($ Millions) & (K Units)
Global Buspirone Market Segment Percentages, by Application, 2022 (%)
Global Buspirone Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions) & (K Units)
Global Buspirone Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Buspirone revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Buspirone revenues share in global market, 2022 (%)
- Key companies Buspirone sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Buspirone sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bristol Myers Squibb
- Apotex
- Dr. Reddy's Laboratories
- Laboratoires Servier
- Teva
- AMAG Pharmaceuticals
- Mylan
- Novartis
- Watson Laboratories
- Hikma
- Wockhardt
- Cadila Healthcare
- Orion Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Buspirone, market overview.
Chapter 2: Global Buspirone market size in revenue and volume.
Chapter 3: Detailed analysis of Buspirone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Buspirone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Buspirone capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
